<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Authorization of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Authorization of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability</h1>
    <p class="timestamp">Published: 2023-06-05 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the issuance of an Emergency Use Authorization (EUA) (the Authorization) under the Federal Food, Drug, and Cosmetic Act (FD&C Act) for use during the COVID-19 pandemic. FDA has issued an Authorization for the drug product GOHIBIC (vilobelimab) as requested by InflaRx GmbH's (InflaRx). The Authorization contains, among other things, conditions on the emergency use of the authorized product. The Authorization follows the February 4, 2020, determ...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-11852</p>
    <p><strong>Publication Date:</strong> 2023-06-05</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/06/05/2023-11852/authorization-of-emergency-use-of-a-drug-product-during-the-covid-19-pandemic-availability">https://www.federalregister.gov/documents/2023/06/05/2023-11852/authorization-of-emergency-use-of-a-drug-product-during-the-covid-19-pandemic-availability</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-11852</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
